Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

HIV recombination in China and surrounding regions: it'S role in transmission and pathogenesis One of the unique traits of the human immunodeficiency virus (HIV) is its ability to generate ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Antiretroviral therapy (ART) can keep HIV suppressed indefinitely, but the virus inserts its genetic blueprints into host cells and establishes a long-lasting reservoir that is nearly impossible to ...

This allows HIV-1 to prioritize its own needs while effectively stalling the host defense mechanisms. Thus, the virus can manipulate the host cell machinery in ways that remain robust even under ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

INSTIs block integrase, an enzyme that HIV uses to put HIV DNA into human DNA inside the CD4 T cells. INSTIs belong ... stop working for them, and the virus could start multiplying.

Antiviral treatments strive to block a virus or halt its replication ... developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study.

(1 Trusted Source HIV weakens the immune system by attacking infection-fighting cells. While antiretroviral therapy controls the virus, it doesn’t cure it. Mount Sinai researchers ...

When HIV enters your bloodstream, it attaches to infection-fighting immune cells called CD4 cells. It penetrates the cells and uses their DNA to make copies of itself. Over time, the virus weakens ...